Advertisement
News
Advertisement

Aveo cuts 75 positions, says drug launch still on track

Tue, 10/30/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

An executive at Aveo Oncology (Nasdaq: AVEO) on Tuesday told Mass High Tech that plans to cut 75 positions - more than half through layoffs - have no bearing on the expected launch of the company’s first drug, now pending approval.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading